Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32
Phase 41

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03656783Phase 3Completed
Effects of Biktarvy on CFR in Stable HIV Patients
HIV
PrincipalinvestigatorStart date: 2018-09-14
NCT01754259Phase 3Completed
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
AnginaCoronary Artery DiseaseDiabetes, Type I+1 more
Principalinvestigator
NCT04417114Phase 4Withdrawn
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
Cardiovascular Risk FactorPsoriasisPsoriatic Arthritis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03656783Phase 3PrincipalInvestigator

Effects of Biktarvy on CFR in Stable HIV Patients

HIV
Completed
NCT01754259Phase 3PrincipalInvestigator

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

AnginaCoronary Artery DiseaseDiabetes, Type I+1 more
Completed
NCT04417114Phase 4PrincipalInvestigator

SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE

Cardiovascular Risk FactorPsoriasisPsoriatic Arthritis
Withdrawn

All 3 trials loaded